| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
35,123,000
|
35,010,000
|
39,327,000
|
36,555,000
| | Cost of Revenue | 19,175,000 | 17,979,000 | 19,435,000 | 19,265,000 | | |
Gross Profit
|
15,948,000
|
17,031,000
|
19,892,000
|
17,290,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 8,573,000 | 8,796,000 | 10,500,000 | 9,153,000 |
|
Non Recurring | 1,029,000 | 1,488,000 | 1,163,000 | 1,122,000 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
6,346,000
|
6,747,000
|
8,229,000
|
7,015,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 6,346,000 | 6,747,000 | 8,229,000 | 7,015,000 |
|
Interest Expense | 2,617,000 | 2,621,000 | 2,960,000 | 2,999,000 |
|
Income Before Tax | 3,729,000 | 4,126,000 | 5,269,000 | 4,016,000 |
|
Income Tax Expense | 308,000 | 506,000 | 818,000 | 525,000 |
|
Minority Interest | (166,000) | 16,000 | (135,000) | (17,000) |
|
|
|
Net Income From Continuing Ops | 3,421,000 | 3,620,000 | 4,451,000 | 3,491,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (122,000) | (109,000) | (305,000) | 17,000 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
3,133,000
|
3,527,000
|
4,011,000
|
3,491,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
3,133,000
|
3,527,000
|
4,011,000
|
3,491,000
|
|
0.41%